A tetracyclic compound with antidepressant effects. Mianserin was previously available internationally, however in most markets it has been phased out in favour of mirtazapine.
For the treatment of depression.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.